Sky Medical Technology partners with clinicians to develop cutting-edge medical products and evidence-based therapies aimed at improving patient outcomes and simplifying treatments.

Sky Medical Technology

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Elihu Thomson

Thomas Edison

GE HealthCare Technologies Inc.

iSono Health develops the ATUSA, an AI-driven portable and automated 3D breast ultrasound scanner, which allows for automated scanning without the need for a trained operator.

iSono Health

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Metric
Company Name	Sky Medical Technology	GE HealthCare Technologies Inc.	iSono Health	Masimo Corporation
Symbol		GEHC		MASI
MSH ID	COM:SKYMEDTECH	COM:GEHEALTHCARE	COM:ISONOHEALTH	COM:MASIMO
Market	PRIVATE	STOCKS	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare
Industry	Medical Technology	Medical - Healthcare Information Services	Medical Devices	Medical - Instruments & Supplies
Country	GB	US	US	US
Stage
Employee Count		51K		3.80K
Website	skymedtech.com	gehealthcare.com	isonohealth.com	masimo.com
LinkedIn		gehealthcare
Founders

Metric
Market Cap	36.12B	5.69B
Enterprise Value
Monthly Web Traffic	1.37M	193.91K
Web Traffic Growth	0.23	0.29
Valuation
Raised Capital	1.17B	750M

Metric
Revenue	19.55B	2.05B
Revenue (LTM)
Revenue (NTM)
Gross Profit	7.92B	1.00B
EBITDA	2.44B	262.60M
Operating Income	2.44B	164.30M
Net Income	3.10B	81.50M
EPS	6.82	1.54
Diluted EPS	6.78	1.51
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.41	0.49
Operating Profit Margin	0.13	0.08
EBITDA Margin	0.12	0.13
Net Profit Margin	0.08	0.04
Return on Equity	0.22	0.06
Return on Assets	0.05	0.03
Return on Capital Employed	0.11	0.06

COM:SKYMEDTECH

Sky Medical Technology

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	19.27	79.31
P/B Ratio	4.68	5.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.15	3.84
EV Multiple	10.08	27.18

Metric
Days Sales Outstanding	84.00	61.56
Days Payables Outstanding	87.39	97.44
Days Inventory Outstanding	64.08	190.43
Operating Cycle	141.20	266.68
Cash Conversion Cycle	51.81	193.68
Asset Turnover	0.61	0.70

Metric
Operating Cash Flow	2.10B	94.10M
Free Cash Flow	1.71B	6.40M
Cash Flow to Debt	0.23	0.24
Operating Cash Flow/Sales	0.11	0.09
Free Cash Flow Yield	0.05	-0.01

Metric
Cash & Equivalents	2.50B	166M
Accounts Receivable	-185M	91.90M
Inventory	1.96B	545M
Goodwill	12.94B	407.70M
Debt to Capitalization	0.58	0.41
Debt to Assets	0.32	0.32
Current Ratio	1.25	2.14
Quick Ratio	0.83	1.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	-0.02	0.00
R&D to Revenue	0.06	0.09
SG&A to Revenue